Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 8.31% | -0.01% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 8.31% | -0.01% | |
| Cost of Revenue | -- | -- | 7.31% | -2.25% | |
| Gross Profit | -- | -- | 10.24% | 4.31% | |
| SG&A Expenses | -- | -- | -7.52% | -19.22% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 1,367.38% | 91.29% | |
| Total Operating Expenses | -- | -- | 3.41% | -9.35% | |
| Operating Income | -- | -- | 14.06% | 40.77% | |
| Income Before Tax | -- | -- | 16.80% | 51.18% | |
| Income Tax Expenses | -- | -- | 923.73% | -47.83% | |
| Earnings from Continuing Operations | -- | -- | 15.34% | 51.34% | |
| Earnings from Discontinued Operations | -- | -- | -104.46% | -100.02% | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -32.34% | 28.89% | |
| EBIT | -- | -- | 14.06% | 40.77% | |
| EBITDA | -- | -- | 16.47% | 45.57% | |
| EPS Basic | -- | -- | 9.98% | 38.90% | |
| Normalized Basic EPS | -- | -- | -45.50% | 47.17% | |
| EPS Diluted | -- | -- | 9.17% | 38.09% | |
| Normalized Diluted EPS | -- | -- | -45.50% | 47.17% | |
| Average Basic Shares Outstanding | -- | -- | 37.12% | 22.49% | |
| Average Diluted Shares Outstanding | -- | -- | 31.25% | 22.49% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |